AMRN said the FDA accepted a new drug for review, while OII updated its financial guidance
Posted on November 25, 2011 at 09:08 AM EST
Checking out a few of today's hot stocks on the move, we've got signs of regulatory progress for Amarin Corporation's (AMRN) experimental triglyceride drug, as well as an updated financial forecast from Oceaneering International (OII). AmarinAmarin Corporation (AMRN - 6.67) announced this morning that the Food and Drug Administration (FDA) has accepted for review an application for AMR101, the company's experimental triglyceride treatment...( Read More )